Five Biotech Milestones – Lab to Success
Developing a molecule from lab to patients requires more than 1,000 decisions, made right and at the right time. However, the […]
Path-to-Market
Targeting the Totality of MS: Jason Tardio on Immunic’s Combined Neuroprotective & Anti-Inflammatory Strategy
Welcome to IDEA Collider with your host, Rick Ritacco. In this episode, we sit down with Jason Tardio, President and
The Future of Psychedelic Medicine: Clinical Strategy and Scaling Access.
Welcome to a special edition of IDEA Collider’s “Deep Medicine” series. In this episode, host Alex Gray sits down with
The Power of the Early Narrative: Sue Wood on Strategic Biotech Positioning
Welcome to IDEA Collider with your host, Rick Ritacco. In this episode, we sit down with Sue Wood, a senior
The Keytruda Blueprint: Alex Gray, David Radwaner, and Tom Brockbank on the IO Revolution
Welcome to IDEA Collider. In this episode, host Dr. Alex Gray is joined by IDEA Pharma colleagues David Radwaner and
The Execution Problem: Alex Gray and Jacqueline Poot on Pharma Decision Intelligence.
Welcome to IDEA Collider. In this episode, host Dr. Alex Gray, Chief Medical and Innovation Officer at IDEA Pharma, is
2026 Global Pharmaceutical Innovation and Invention Index
The annual ranking of the world’s leading pharma companies by their ability to create new ideas and turn them into
2026 Freshness Index
The Freshness Index shows the percentage of company sales generated by products launched in the last three and five years.
IDEA Pharma is a proud partner of Candel Therapeutics
Through an integrated partnership with EVERSANA and CANDEL, we are helping to change patient lives by maximizing the potential of aglatimagene besadenovec to raise the standards
Creating the Right Answer: The Fulcrum EVOLVE™ Framework for Pharmaceutical Positioning
Creating the Right Answer: The Fulcrum EVOLVE™ Framework for Pharmaceutical Positioning Introduction: The Wrong Question Pharmaceutical market research is often